Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement

Completed · Not applicable · Has a placebo group

Conditions studied: Candida Systemic, Candida Albicans Infection, Candida Infection

In brief

This is a virtual, double-blind, two-arm, randomized, placebo-controlled clinical trial that will last 12 weeks. Participants will take the CanXida Remove Candida Cleansing Formula RMV or a placebo product daily and complete questionnaires at Baseline, Week 6, and Week 12. Candida microbiome testing will be conducted via stool sample at Baseline and Week 12. The participants will all be blinded to the name of the test brand.

Key facts

Study ID

NCT06146504

Run by

CanXida

People needed

60

Starts

2023-11-30

Expected to finish

2024-06-28

Last updated by the study team

2024-08-22

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Aged between 18-50.
• Female.
• Self-reported recurrent vaginal issues, including:
• Itching and irritation in and around the vaginal area.
• Burning sensation during urination or sexual intercourse.
• Abnormal discharge (e.g. thicker, white, and curd-like in appearance, odorless, or with a mild yeasty smell.
• Redness and swelling of the vulva and surrounding skin
• Pain or discomfort in the vaginal area or lower abdomen.
• Urinary tract infections
• Vaginal thrush
• May also experience issues with fatigue, lethargy, and gut or digestive issues.
• Willing to provide two stool samples during the study.
• Willing to adhere to the study protocol.
• Willing to avoid introducing any products or any new forms of regular medication or supplements that target candida overgrowth, gut health, or vaginal health for the duration of the study.

You may not qualify if…

• Anyone with severe chronic conditions including oncological conditions, psychiatric disease, diabetes, or other.
• Anyone with known severe allergic reactions or is allergic to the test product or placebo ingredients.
• Currently taking any antibiotics or will be during the trial period.
• Anymore diagnosed with a sexually transmitted disease within the last three months e.g. Chlamydia, trichomoniasis, gonorrhea, genital herpes
• Women who are pregnant, breastfeeding, or attempting to become pregnant.
• Having any planned invasive medical procedures during the study period.
• Currently participating in any other clinical study.
• History of substance abuse.
• Unwilling to follow the study protocol.

Where it is running

• Citruslabs — Santa Monica, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.